Zakariya Al Naamani1, Kevin Gormley2, Helen Noble3, Olinda Santin3, Mohammed Al Maqbali4. 1. School of Nursing and Midwifery, Queens's University Belfast, Belfast, UK. zalnaamani01@qub.ac.uk. 2. College of Nursing and Midwifery, Mohammed Bin Rashid University of Medicine and Health Science, Dubai, UAE. 3. School of Nursing and Midwifery, Queens's University Belfast, Belfast, UK. 4. Ministry of Health, Muscat, Oman.
Abstract
OBJECTIVE: Patients undergoing haemodialysis may experience troubling symptoms such as fatigue, anxiety, depression and sleep quality, which may affect their quality of life. The main objective of this study is to determine the prevalence of fatigue, anxiety, depression and sleep quality among patients receiving haemodialysis during the coronavirus disease 2019 (COVID-19) pandemic, and to explore the contributing predictors. METHODS: A cross-sectional and descriptive correlational design using Qualtrics software was performed. Data were collected using the Functional Assessment of Cancer Therapy-Fatigue (FACT-F), the Hospital Anxiety and Depression Scale (HADS) and the Pittsburgh Sleep Quality Index (PSQI). Logistic regression analyses were used to explore the predictors that were associated with fatigue, anxiety, depression and sleep quality. RESULTS: Of the 123 patients undergoing haemodialysis who participated, 53.7% (n = 66) reported fatigue, 43.9% (n = 54) reported anxiety, 33.3% (n = 41) reported depression and 56.9% (n = 70) reported poor sleep. Fatigue, anxiety and sleep quality (P < .05) were significantly associated with being female, and whether family members or relatives were suspected or confirmed with COVID-19. Logistic regression showed that being within the age group 31-40, having a secondary education level, anxiety, depression and sleep quality were the main predictors affecting the fatigue group. CONCLUSION: Fatigue, anxiety, depression and sleep quality are significant problems for patients receiving haemodialysis during the COVID-19 pandemic. Appropriate interventions to monitor and reduce fatigue, psychological problems and sleep quality amongst these patients are needed. This can help to strengthen preparations for responding to possible future outbreaks or pandemics of infectious diseases for patients receiving haemodialysis.
OBJECTIVE:Patients undergoing haemodialysis may experience troubling symptoms such as fatigue, anxiety, depression and sleep quality, which may affect their quality of life. The main objective of this study is to determine the prevalence of fatigue, anxiety, depression and sleep quality among patients receiving haemodialysis during the coronavirus disease 2019 (COVID-19) pandemic, and to explore the contributing predictors. METHODS: A cross-sectional and descriptive correlational design using Qualtrics software was performed. Data were collected using the Functional Assessment of Cancer Therapy-Fatigue (FACT-F), the Hospital Anxiety and Depression Scale (HADS) and the Pittsburgh Sleep Quality Index (PSQI). Logistic regression analyses were used to explore the predictors that were associated with fatigue, anxiety, depression and sleep quality. RESULTS: Of the 123 patients undergoing haemodialysis who participated, 53.7% (n = 66) reported fatigue, 43.9% (n = 54) reported anxiety, 33.3% (n = 41) reported depression and 56.9% (n = 70) reported poor sleep. Fatigue, anxiety and sleep quality (P < .05) were significantly associated with being female, and whether family members or relatives were suspected or confirmed with COVID-19. Logistic regression showed that being within the age group 31-40, having a secondary education level, anxiety, depression and sleep quality were the main predictors affecting the fatigue group. CONCLUSION:Fatigue, anxiety, depression and sleep quality are significant problems for patients receiving haemodialysis during the COVID-19 pandemic. Appropriate interventions to monitor and reduce fatigue, psychological problems and sleep quality amongst these patients are needed. This can help to strengthen preparations for responding to possible future outbreaks or pandemics of infectious diseases for patients receiving haemodialysis.
Authors: Richard W Corbett; Sarah Blakey; Dorothea Nitsch; Marina Loucaidou; Adam McLean; Neill Duncan; Damien R Ashby Journal: J Am Soc Nephrol Date: 2020-06-19 Impact factor: 10.121
Authors: Abdullah Sulieman Terkawi; Siny Tsang; Ghadah Jumaan AlKahtani; Sumaya Hussain Al-Mousa; Salma Al Musaed; Usama Saleh AlZoraigi; Esraa M Alasfar; Khalid S Doais; Anas Abdulrahman; Khaild Ali Altirkawi Journal: Saudi J Anaesth Date: 2017-05
Authors: Marian Goicoechea; Luis Alberto Sánchez Cámara; Nicolás Macías; Alejandra Muñoz de Morales; Ángela González Rojas; Arturo Bascuñana; David Arroyo; Almudena Vega; Soraya Abad; Eduardo Verde; Ana María García Prieto; Úrsula Verdalles; Diego Barbieri; Andrés Felipe Delgado; Javier Carbayo; Antonia Mijaylova; Adriana Acosta; Rosa Melero; Alberto Tejedor; Patrocinio Rodriguez Benitez; Ana Pérez de José; María Luisa Rodriguez Ferrero; Fernando Anaya; Manuel Rengel; Daniel Barraca; José Luño; Inés Aragoncillo Journal: Kidney Int Date: 2020-05-11 Impact factor: 10.612
Authors: Loan T Dang; Thuc C Luong; Dung H Nguyen; Trung A Hoang; Hoai T Nguyen; Hoang C Nguyen; Thai H Duong; Tu T Tran; Linh V Pham; Tuan V Ngo; Hoi T Nguyen; Nga T Trieu; Thinh V Do; Manh V Trinh; Tung H Ha; Dung T Phan; Binh N Do; Shwu-Huey Yang; Tsae-Jyy Wang; Tuyen Van Duong Journal: Nutrients Date: 2022-06-07 Impact factor: 6.706
Authors: Yan Liu; Ji Shu Xian; Rui Wang; Kang Ma; Fei Li; Fei Long Wang; Xue Yang; Ning Mu; Kai Xu; Yu Lian Quan; Shi Wang; Ying Lai; Chuan Yan Yang; Teng Li; Yanchun Zhang; Binbin Tan; Hua Feng; Tu Nan Chen; Li Hua Wang Journal: Front Psychiatry Date: 2022-08-25 Impact factor: 5.435